drugset / Trial / NCT02414737

Ovarian Stimulation Single Injection Elonva

NCT02414737

Phase 3 Completed 20 enrolled Flinders Fertility Flinders University · collab
NaSingle-groupOpen-labelTreatment

Summary

We would like to propose that it may be possible to use a solitary dose of Elonva (corifollitrophin alpha) as the sole gonadotrophin (FSH) stimulant for the vast majority of women undergoing IVF, assuming that it is possible that "coasting" (withholding short acting rFSH) from day 8 of the stimulation until trigger/ oocyte retrieval will still result in a significant number of mature oocytes being produced and an acceptable pregnancy rate.

Timeline

Start
2016-02
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Corifollitropin alfa Protein / enzyme biologic

Indications